methylene blue has been researched along with (3,4-dihydroxyphenylamino)-2-imidazoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beasley, D; McGuiggin, M | 1 |
| Cheng, X; Pang, CC; Wang, YX | 1 |
2 other study(ies) available for methylene blue and (3,4-dihydroxyphenylamino)-2-imidazoline
| Article | Year |
|---|---|
Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
Topics: Amino Acid Oxidoreductases; Aminoquinolines; Animals; Arginine; Base Sequence; Catecholamines; Cells, Cultured; Cyclic GMP; DNA Primers; Enzyme Activation; Guanylate Cyclase; Humans; Imidazolines; Interferon-gamma; Interleukin-1; Lipopolysaccharides; Methylene Blue; Molecular Sequence Data; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Polymerase Chain Reaction; Rats; RNA, Messenger; Tumor Necrosis Factor-alpha | 1994 |
Vascular pharmacology of methylene blue in vitro and in vivo: a comparison with NG-nitro-L-arginine and diphenyleneiodonium.
Topics: Acetylcholine; Animals; Aorta; Arginine; Catecholamines; Dose-Response Relationship, Drug; Imidazolines; Methylene Blue; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Nitroprusside; Purinones; Rats; Rats, Sprague-Dawley | 1995 |